patient_id large_string | visit_number int64 | visit_date large_string | years_from_baseline float64 | age_at_visit float64 | sex large_string | race_ethnicity large_string | htn_stage_baseline large_string | sbp_office_mmhg float64 | dbp_office_mmhg float64 | pp_office_mmhg float64 | map_office_mmhg float64 | sbp_home_avg_mmhg float64 | dbp_home_avg_mmhg float64 | abpm_sbp_24hr_mmhg float64 | abpm_dbp_24hr_mmhg float64 | abpm_sbp_daytime_mmhg float64 | abpm_sbp_nighttime_mmhg float64 | abpm_dipping_pct float64 | abpm_dipping_pattern large_string | central_aortic_sbp_mmhg float64 | pulse_wave_velocity_ms float64 | augmentation_index_pct float64 | bp_variability_sd_sbp float64 | white_coat_effect_mmhg float64 | white_coat_flag int64 | masked_hypertension_flag int64 | drug_class_1 large_string | drug_name_1 large_string | drug_dose_1 large_string | drug_class_2 large_string | drug_name_2 large_string | drug_class_3 large_string | drug_name_3 large_string | drug_class_4 large_string | drug_name_4 large_string | n_antihypertensive_drugs int64 | medication_adherence_pct float64 | bp_response_sbp_mmhg float64 | resistant_htn_flag int64 | side_effect_code large_string | pill_burden_score int64 | bmi_kg_m2 float64 | dietary_sodium_mg_day int64 | dash_diet_score float64 | physical_activity_mets_hr_wk float64 | sleep_hours_night float64 | smoking_status large_string | alcohol_drinks_week float64 | stress_score float64 | total_cholesterol_mg_dl float64 | ldl_cholesterol_mg_dl float64 | hdl_cholesterol_mg_dl float64 | triglycerides_mg_dl float64 | non_hdl_cholesterol_mg_dl float64 | hs_crp_mg_l float64 | creatinine_mg_dl float64 | egfr_ml_min_1_73m2 float64 | uacr_mg_g float64 | ckd_stage large_string | bun_mg_dl float64 | potassium_meq_l float64 | sodium_meq_l float64 | glucose_fasting_mg_dl float64 | hba1c_pct float64 | uric_acid_mg_dl float64 | bnp_pg_ml float64 | troponin_i_ng_l float64 | ascvd_10yr_risk_pct float64 | framingham_risk_score_pct float64 | microalbuminuria_flag int64 | macroalbuminuria_flag int64 | lvh_flag int64 | lv_mass_index_g_m2 float64 | lvef_pct float64 | e_e_prime_ratio float64 | carotid_imt_mm float64 | carotid_plaque_flag int64 | retinopathy_grade int64 | wml_volume_ml float64 | lacunar_infarct_flag int64 | mace_event_flag int64 | mace_event_type large_string | mi_flag int64 | stroke_flag int64 | stroke_type large_string | hf_hospitalization_flag int64 | af_new_onset_flag int64 | cardiovascular_death_flag int64 | all_cause_death_flag int64 | study_dropout_flag int64 | dropout_reason large_string | diabetes_flag int64 | dyslipidemia_flag int64 | osa_flag int64 | statin_use_flag int64 | aspirin_use_flag int64 | family_history_htn_flag int64 | charlson_comorbidity_index int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HC-CAR-000147 | 2 | 2015-07-01 | 0.5 | 75 | Female | NonHispanic_White | Stage1_HTN | 126.4 | 80.9 | 45.5 | 96.1 | 116.2 | 75.8 | 114.2 | 76.2 | 121 | 112.9 | 6.7 | Non-dipper | 121.3 | 12.61 | 30 | 11.4 | 10.2 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 84.3 | 2.5 | 0 | None | 1 | 33.6 | 4,657 | 53.1 | 3.1 | 6.8 | Former | 4.5 | 7.7 | 121.2 | 134.1 | 68 | 135.2 | 53.2 | 0.7 | 1.17 | 56.8 | 42 | G3a | 19.5 | 3.48 | 139.5 | 95.5 | 5.4 | 3.3 | 18.6 | 26.39 | 75 | 50 | 1 | 0 | 0 | 121.4 | 63.7 | 6.4 | 1.5 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 3 | 2015-10-01 | 0.75 | 75.2 | Female | NonHispanic_White | Stage1_HTN | 132.5 | 86 | 46.5 | 101.5 | 134.7 | 87.1 | 135.9 | 85.2 | 143.8 | 120.3 | 16.3 | Dipper | 123.3 | 11.61 | 26.8 | 5 | -2.3 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 86.1 | 12.8 | 0 | Peripheral_Edema | 1 | 33 | 4,658 | 49.3 | 3.1 | 7.1 | Former | 4.7 | 10.2 | 124 | 141.9 | 71.7 | 116.9 | 52.3 | 0.97 | 1.25 | 52.7 | 24.6 | G3a | 19 | 3.35 | 138.6 | 79.2 | 5.7 | 3 | 12.3 | 14.48 | 75 | 50 | 0 | 0 | 0 | 124.9 | 64 | 5 | 1.5 | 1 | 0 | 25 | 0 | 1 | HF_Hospitalization | 0 | 0 | None | 1 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 4 | 2016-01-01 | 1 | 75.5 | Female | NonHispanic_White | Stage1_HTN | 138.2 | 80.4 | 57.8 | 99.7 | 131.9 | 77.2 | 124.7 | 73.8 | 131.6 | 113 | 14.1 | Dipper | 130.1 | 13.07 | 26.7 | 17.4 | 6.3 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 82.5 | 7.4 | 0 | None | 1 | 33.3 | 4,830 | 50.9 | 2.9 | 7 | Former | 4.7 | 14.5 | 132.8 | 145.1 | 70.4 | 117.2 | 62.5 | 1.08 | 1.24 | 58.7 | 29.6 | G3a | 15.7 | 3.32 | 142.6 | 94.5 | 5.6 | 2.9 | 10.9 | 29.62 | 75 | 50 | 0 | 0 | 0 | 118.8 | 64.5 | 5.2 | 1.492 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 5 | 2016-04-01 | 1.25 | 75.8 | Female | NonHispanic_White | Stage1_HTN | 132.8 | 90.1 | 42.7 | 104.3 | 119.6 | 83.5 | 115.9 | 80.7 | 122.8 | 98 | 20.2 | Extreme_dipper | 127.5 | 10.66 | 26.4 | 21.5 | 13.2 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 79.3 | 11.4 | 0 | None | 1 | 33.1 | 4,731 | 50.4 | 3.9 | 7.4 | Former | 4.5 | 13.1 | 131.5 | 144.6 | 69.3 | 103.9 | 62.1 | 0.66 | 1.33 | 57.6 | 26.7 | G3a | 20.3 | 3.71 | 139 | 90.2 | 5.5 | 3 | 12.5 | 45.46 | 75 | 50 | 0 | 0 | 0 | 116.1 | 66.9 | 5.2 | 1.498 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 6 | 2016-07-01 | 1.5 | 76 | Female | NonHispanic_White | Stage1_HTN | 139.9 | 84.5 | 55.5 | 102.9 | 134.8 | 81.9 | 127.5 | 78.9 | 135.9 | 114.3 | 15.9 | Dipper | 127.6 | 12.6 | 32.7 | 12.3 | 5.1 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 86.6 | 9 | 0 | None | 1 | 33.2 | 4,685 | 51.5 | 3.8 | 7.1 | Former | 4.9 | 19 | 126.8 | 145.8 | 69.4 | 111.9 | 57.4 | 0.66 | 1.23 | 57.6 | 36.6 | G3a | 16.8 | 3.36 | 138.4 | 98.5 | 5.5 | 2.8 | 11.2 | 43.25 | 75 | 50 | 1 | 0 | 0 | 125.7 | 62 | 5.1 | 1.482 | 1 | 0 | 24.67 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 7 | 2016-10-01 | 1.75 | 76.2 | Female | NonHispanic_White | Stage1_HTN | 134.6 | 92.1 | 42.5 | 106.3 | 133.3 | 91.5 | 133.5 | 87.7 | 137.8 | 111.3 | 19.2 | Dipper | 125.3 | 11.96 | 30.9 | 14.2 | 1.3 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 84.2 | 10.5 | 0 | None | 1 | 33.1 | 4,754 | 49.4 | 2.7 | 6.9 | Former | 4.1 | 13.3 | 123.9 | 139.8 | 68.1 | 106.3 | 55.8 | 0.85 | 1.35 | 56.7 | 33.3 | G3a | 19.2 | 3.57 | 138.7 | 95 | 5.6 | 3.3 | 11.1 | 20.08 | 75 | 50 | 1 | 0 | 0 | 123.2 | 63 | 5.7 | 1.5 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 8 | 2017-01-01 | 2 | 76.5 | Female | NonHispanic_White | Stage1_HTN | 139.3 | 84.1 | 55.2 | 102.5 | 132.2 | 80.5 | 130.5 | 76.5 | 137.5 | 111 | 19.3 | Dipper | 134 | 11.87 | 27.4 | 11.8 | 7.1 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 88.9 | 11.4 | 0 | None | 1 | 33.2 | 4,813 | 51.7 | 3 | 7.4 | Former | 4.2 | 11.9 | 135 | 137.5 | 70.7 | 112.9 | 64.3 | 0.74 | 1.24 | 57.1 | 28.2 | G3a | 17.3 | 3.29 | 137.6 | 79.8 | 5.5 | 2.8 | 16.9 | 29.07 | 75 | 50 | 0 | 0 | 0 | 121.4 | 61.5 | 5.9 | 1.5 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 9 | 2017-04-01 | 2.25 | 76.8 | Female | NonHispanic_White | Stage1_HTN | 144.3 | 95 | 49.3 | 111.5 | 154.3 | 100 | 146.4 | 99.6 | 158.2 | 130.8 | 17.3 | Dipper | 131 | 13.27 | 25.6 | 7.8 | -10 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 89.3 | 11.2 | 0 | Peripheral_Edema | 1 | 33.3 | 4,754 | 52.4 | 3.5 | 7.2 | Former | 4.3 | 15.8 | 120.9 | 152.8 | 66.3 | 119.4 | 54.6 | 0.68 | 1.38 | 57.8 | 21.4 | G3a | 18.1 | 3.98 | 140.6 | 89.2 | 5.3 | 3 | 11.6 | 33.9 | 75 | 50 | 0 | 0 | 0 | 116.4 | 64.3 | 5.3 | 1.492 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 10 | 2017-07-01 | 2.5 | 77 | Female | NonHispanic_White | Stage1_HTN | 136.4 | 95 | 41.4 | 108.8 | 121.8 | 87.7 | 121.5 | 86.3 | 127.1 | 102.5 | 19.3 | Dipper | 123.5 | 11.91 | 27.1 | 8.2 | 14.6 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 83.2 | 12.3 | 0 | None | 1 | 33 | 4,699 | 49.5 | 4.1 | 7.1 | Former | 4.9 | 11.5 | 125.4 | 147 | 69.1 | 121 | 56.3 | 0.91 | 1.19 | 55.9 | 18 | G3a | 22.6 | 3.39 | 139.6 | 92.4 | 5.4 | 2.9 | 9.2 | 37.2 | 75 | 50 | 0 | 0 | 0 | 124.7 | 64 | 5.9 | 1.5 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 11 | 2017-10-01 | 2.75 | 77.2 | Female | NonHispanic_White | Stage1_HTN | 132.9 | 86.9 | 46 | 102.2 | 124.7 | 82.8 | 116.8 | 79.1 | 126.7 | 113 | 10.8 | Dipper | 127.7 | 13.2 | 27.2 | 10 | 8.2 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 76.8 | 3.2 | 0 | None | 1 | 33.4 | 4,775 | 52.3 | 5.3 | 6.8 | Former | 3.8 | 11.9 | 126.9 | 147.9 | 67.7 | 105.7 | 59.1 | 0.9 | 1.3 | 59.8 | 29.7 | G3a | 18.5 | 3.7 | 139.4 | 88.8 | 5.5 | 3.4 | 20.3 | 31 | 75 | 50 | 0 | 0 | 0 | 123.6 | 64.5 | 5.3 | 1.5 | 1 | 0 | 24.84 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000147 | 12 | 2018-01-01 | 3 | 77.5 | Female | NonHispanic_White | Stage1_HTN | 132.4 | 84 | 48.4 | 100.1 | 122.2 | 78.9 | 118.3 | 79.4 | 128.9 | 122 | 5.3 | Non-dipper | 123.2 | 12.6 | 28.3 | 5.7 | 10.2 | 0 | 0 | CCB | Verapamil | 10mg | None | None | None | None | None | None | 1 | 87.4 | 10.3 | 0 | None | 1 | 33 | 4,658 | 51.7 | 3.7 | 7.3 | Former | 3.9 | 12.8 | 131.6 | 154.1 | 72 | 125.4 | 59.6 | 0.9 | 1.21 | 54.1 | 24.4 | G3a | 17.6 | 3.76 | 137.8 | 78.7 | 5.3 | 2.3 | 12.5 | 29.54 | 75 | 50 | 0 | 0 | 0 | 121.9 | 58.7 | 5.7 | 1.5 | 1 | 0 | 25 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
HC-CAR-000148 | 1 | 2015-04-01 | 0.25 | 59.4 | Male | NonHispanic_White | Stage2_HTN | 170.6 | 129.6 | 41 | 143.3 | 156.8 | 122.7 | 150 | 120 | 156.6 | 146.3 | 6.6 | Non-dipper | 164.8 | 11.73 | 18.7 | 13.5 | 13.9 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 82.8 | 15.6 | 0 | Hyperkalemia | 2 | 26.8 | 2,267 | 28.4 | 12.9 | 6.7 | Former | 0.1 | 9 | 209.7 | 91.1 | 35.3 | 273.2 | 174.4 | 0.43 | 0.78 | 92.5 | 51.9 | G1 | 16.1 | 4.76 | 142.2 | 70 | 4.5 | 6 | 66.8 | 1.66 | 75 | 50 | 1 | 0 | 1 | 126.8 | 62.8 | 15.9 | 1.44 | 1 | 1 | 5.77 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 2 | 2015-07-01 | 0.5 | 59.6 | Male | NonHispanic_White | Stage2_HTN | 178.7 | 130 | 48.7 | 146.2 | 174.8 | 125 | 175.7 | 120 | 184.7 | 159.3 | 13.7 | Dipper | 169.4 | 12.38 | 17.7 | 11.6 | 3.9 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 78.7 | 19.8 | 0 | None | 2 | 26.9 | 2,260 | 26.5 | 13.2 | 6.8 | Former | 0 | 6.3 | 206.4 | 88.3 | 35.4 | 228.7 | 171 | 0.42 | 0.63 | 93 | 55.6 | G1 | 14.4 | 4.95 | 144.4 | 74.9 | 4.5 | 6.1 | 64.5 | 1.39 | 75 | 50 | 1 | 0 | 1 | 118.4 | 60.5 | 15.7 | 1.432 | 1 | 1 | 5.73 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 3 | 2015-10-01 | 0.75 | 59.9 | Male | NonHispanic_White | Stage2_HTN | 179.6 | 123.8 | 55.8 | 142.4 | 174.7 | 121.3 | 175 | 118 | 185 | 170.7 | 7.8 | Non-dipper | 169.4 | 12.87 | 14.1 | 14.1 | 4.9 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 65.7 | 8.2 | 0 | None | 2 | 26.5 | 2,577 | 27.8 | 11.5 | 7.1 | Former | 0.1 | 3.5 | 210.7 | 102.6 | 36.4 | 209.1 | 174.3 | 0.32 | 0.71 | 89.3 | 72.8 | G2 | 16.2 | 4.84 | 143.6 | 70 | 4.5 | 6.1 | 71.7 | 1.77 | 75 | 50 | 1 | 0 | 1 | 123.5 | 64.4 | 16 | 1.468 | 1 | 1 | 5.41 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 4 | 2016-01-01 | 1 | 60.1 | Male | NonHispanic_White | Stage2_HTN | 169.9 | 128.7 | 41.2 | 142.4 | 158.7 | 123 | 152.8 | 120 | 162.3 | 151.5 | 6.7 | Non-dipper | 159.8 | 11.86 | 18 | 17.2 | 11.3 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 69.7 | 15.7 | 0 | Hyperkalemia | 2 | 26.6 | 2,369 | 26.9 | 12.3 | 6.8 | Former | 0 | 7.9 | 207.5 | 87 | 34.3 | 245.9 | 173.2 | 0.43 | 0.69 | 91 | 43.6 | G1 | 14.9 | 5.05 | 142 | 70 | 4.5 | 5.9 | 37.8 | 1.58 | 75 | 50 | 1 | 0 | 1 | 120.7 | 63.2 | 15.3 | 1.452 | 1 | 1 | 5.71 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 5 | 2016-04-01 | 1.25 | 60.4 | Male | NonHispanic_White | Stage2_HTN | 183.2 | 122.8 | 60.4 | 143 | 170.4 | 116.4 | 167.4 | 117.4 | 173.2 | 158.4 | 8.5 | Non-dipper | 174 | 12.39 | 14.5 | 10.4 | 12.8 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 75.7 | 13.7 | 0 | None | 2 | 26.4 | 2,417 | 28.7 | 11.7 | 7.1 | Former | 0 | 5 | 213.8 | 85.1 | 32.5 | 228.5 | 181.2 | 0.55 | 0.72 | 95.5 | 36.8 | G1 | 13.5 | 4.85 | 141.6 | 80.7 | 4.5 | 5.8 | 108.6 | 1.72 | 75 | 50 | 1 | 0 | 1 | 129.9 | 62.5 | 16.9 | 1.475 | 1 | 1 | 5.38 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 6 | 2016-07-01 | 1.5 | 60.6 | Male | NonHispanic_White | Stage2_HTN | 173.5 | 123.7 | 49.8 | 140.3 | 170.4 | 122.2 | 167.9 | 120 | 174.9 | 149.1 | 14.7 | Dipper | 161 | 13.17 | 18.2 | 9.9 | 3.1 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 67.3 | 17.2 | 0 | Hyperkalemia | 2 | 26.3 | 2,227 | 28.9 | 11.8 | 7.2 | Former | 0 | 6.6 | 207.4 | 88.6 | 33.9 | 231.1 | 173.5 | 0.44 | 0.69 | 91.9 | 25 | G1 | 11.4 | 4.78 | 142.3 | 70 | 4.7 | 6 | 62.8 | 1.34 | 75 | 50 | 0 | 0 | 1 | 123.4 | 63.1 | 15.7 | 1.436 | 1 | 1 | 6.24 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 7 | 2016-10-01 | 1.75 | 60.9 | Male | NonHispanic_White | Stage2_HTN | 185.6 | 128.8 | 56.8 | 147.7 | 177.1 | 124.6 | 171.9 | 119.9 | 175.9 | 160.6 | 8.7 | Non-dipper | 172.8 | 12.94 | 15.9 | 5 | 8.5 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 69.7 | 19.3 | 0 | None | 2 | 26.7 | 2,314 | 31.6 | 12.9 | 7.1 | Former | 0.5 | 6.9 | 210.7 | 95.2 | 30.6 | 225 | 180.1 | 0.47 | 0.75 | 90.6 | 37.1 | G1 | 17.8 | 5.16 | 143.7 | 70.9 | 4.5 | 6 | 43.6 | 2.24 | 75 | 50 | 1 | 0 | 1 | 122.8 | 60.2 | 16.4 | 1.49 | 1 | 1 | 5.38 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 8 | 2017-01-01 | 2 | 61.1 | Male | NonHispanic_White | Stage2_HTN | 177.6 | 126.4 | 51.2 | 143.4 | 161.2 | 118.2 | 162.6 | 115.5 | 174.7 | 164.3 | 5.9 | Non-dipper | 171.3 | 13.58 | 16.5 | 12.6 | 16.4 | 1 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 70 | 9.3 | 0 | Hyperkalemia | 2 | 26.5 | 2,281 | 25.6 | 11.6 | 7.3 | Former | 0.1 | 5.5 | 207.3 | 87.9 | 34.7 | 180.6 | 172.6 | 0.42 | 0.7 | 92.9 | 38.7 | G1 | 15.2 | 4.77 | 142.6 | 70 | 4.7 | 6 | 59 | 2.27 | 75 | 50 | 1 | 0 | 1 | 118 | 59.8 | 15.7 | 1.483 | 1 | 1 | 5.73 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 9 | 2017-04-01 | 2.25 | 61.4 | Male | NonHispanic_White | Stage2_HTN | 171 | 122.2 | 48.8 | 138.5 | 157.9 | 115.7 | 149.2 | 111.9 | 154.8 | 136.2 | 12 | Dipper | 165 | 13.21 | 20.3 | 7.2 | 13.1 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 71.8 | 12.3 | 0 | None | 2 | 26.7 | 2,446 | 25.6 | 12.4 | 7.3 | Former | 0.3 | 4.6 | 201.2 | 102.8 | 35.8 | 195.3 | 165.4 | 0.52 | 0.63 | 92.4 | 31 | G1 | 15.8 | 4.93 | 143.1 | 71.8 | 4.6 | 5.8 | 138.5 | 2.19 | 75 | 50 | 1 | 0 | 1 | 124.1 | 57.4 | 16.7 | 1.496 | 1 | 1 | 5.48 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 10 | 2017-07-01 | 2.5 | 61.6 | Male | NonHispanic_White | Stage2_HTN | 179.1 | 128 | 51 | 145 | 180.5 | 125 | 171.7 | 120 | 179.1 | 165.3 | 7.7 | Non-dipper | 167.6 | 13.26 | 20 | 11.5 | -1.4 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 64.3 | 11.7 | 0 | Bradycardia | 2 | 26.9 | 2,198 | 25.3 | 13 | 7 | Former | 0.3 | 5.6 | 213.2 | 92.4 | 35.5 | 250 | 177.7 | 0.51 | 0.74 | 88.9 | 37.4 | G2 | 15.7 | 4.78 | 142.3 | 70.5 | 4.5 | 5.8 | 77.1 | 1.51 | 75 | 50 | 1 | 0 | 1 | 120.4 | 61.1 | 15.6 | 1.477 | 1 | 1 | 5.69 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 11 | 2017-10-01 | 2.75 | 61.9 | Male | NonHispanic_White | Stage2_HTN | 170.8 | 124 | 46.8 | 139.6 | 168.4 | 122.8 | 168.3 | 120 | 175.6 | 149.7 | 14.8 | Dipper | 157.1 | 12.62 | 15.6 | 5.9 | 2.4 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 76.6 | 12.7 | 0 | None | 2 | 26.7 | 2,347 | 31.4 | 11.6 | 7.3 | Former | 1.1 | 4.3 | 210.1 | 89.6 | 36.3 | 235 | 173.9 | 0.4 | 0.8 | 88.5 | 42 | G2 | 15.8 | 4.96 | 142 | 71.5 | 4.5 | 6.1 | 92.8 | 1.35 | 75 | 50 | 1 | 0 | 1 | 115.7 | 62.4 | 16 | 1.5 | 1 | 1 | 5.32 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000148 | 12 | 2018-01-01 | 3 | 62.1 | Male | NonHispanic_White | Stage2_HTN | 183 | 130 | 53 | 147.7 | 178 | 125 | 177.3 | 120 | 186 | 174.3 | 6.3 | Non-dipper | 172.1 | 12.75 | 16.6 | 10.5 | 5.1 | 0 | 0 | Beta_blocker | Carvedilol | 12.5-50mg | MRA | Eplerenone | None | None | None | None | 2 | 61.1 | 6.6 | 0 | None | 2 | 26.8 | 2,388 | 26.7 | 13.3 | 6.8 | Former | 0.5 | 7.9 | 209.5 | 89.5 | 32.8 | 206.7 | 176.7 | 0.37 | 0.74 | 87 | 68.5 | G2 | 15.8 | 4.88 | 144.3 | 70 | 4.5 | 6.1 | 93.6 | 1.27 | 75 | 50 | 1 | 0 | 1 | 118 | 62.5 | 17.5 | 1.5 | 1 | 1 | 5.7 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 1 | 0 | 0 | 0 | 1 | 2 |
HC-CAR-000149 | 1 | 2015-04-01 | 0.25 | 78.2 | Female | NonHispanic_White | Stage1_HTN | 134.5 | 77.6 | 56.9 | 96.5 | 138.4 | 79.5 | 137.2 | 78.3 | 151.5 | 137.5 | 9.2 | Non-dipper | 125.7 | 9.95 | 34.8 | 13 | -3.9 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 80.9 | 15 | 1 | None | 3 | 33.1 | 3,837 | 20.3 | 2.4 | 7.1 | Never | 3.2 | 12.4 | 227.8 | 82.6 | 61.1 | 225.8 | 166.7 | 0.92 | 0.97 | 71.2 | 30.3 | G2 | 13.4 | 3.82 | 142.3 | 120.9 | 6.6 | 5.8 | 8.9 | 1.15 | 75 | 50 | 1 | 0 | 0 | 60 | 63 | 9.3 | 1.5 | 1 | 0 | 5.38 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 2 | 2015-07-01 | 0.5 | 78.5 | Female | NonHispanic_White | Stage1_HTN | 137 | 80.5 | 56.5 | 99.3 | 127 | 75.5 | 124.2 | 73.2 | 132.6 | 117.7 | 11.3 | Dipper | 126.4 | 10.12 | 35.9 | 9.6 | 10 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 96.4 | 37.7 | 1 | Dry_Cough | 3 | 33.6 | 3,876 | 18.4 | 5.3 | 6.8 | Never | 3.8 | 13.1 | 226.5 | 84.4 | 62.5 | 230.4 | 164 | 1.04 | 0.96 | 70 | 29.5 | G2 | 12.7 | 4.34 | 141.5 | 128.5 | 6.2 | 6.3 | 13 | 1.96 | 75 | 50 | 0 | 0 | 0 | 60 | 54.5 | 9.1 | 1.499 | 1 | 0 | 5.37 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 3 | 2015-10-01 | 0.75 | 78.8 | Female | NonHispanic_White | Stage1_HTN | 137.6 | 80.5 | 57.1 | 99.6 | 131.4 | 77.4 | 127.1 | 76.5 | 132.3 | 99.1 | 25.1 | Extreme_dipper | 123.7 | 9.97 | 35.1 | 5.8 | 6.2 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 81.8 | 25.5 | 1 | Peripheral_Edema | 3 | 33.5 | 3,882 | 18 | 4 | 6.7 | Never | 3.6 | 11.9 | 226.7 | 81.9 | 63.4 | 225.8 | 163.3 | 0.76 | 1.03 | 65.6 | 13 | G2 | 11 | 4.26 | 143.2 | 142.2 | 6.8 | 5.7 | 40 | 3.3 | 75 | 50 | 0 | 0 | 0 | 60.4 | 61 | 9.4 | 1.5 | 1 | 0 | 5.22 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 4 | 2016-01-01 | 1 | 79 | Female | NonHispanic_White | Stage1_HTN | 140.2 | 77.6 | 62.6 | 98.5 | 122.7 | 68.9 | 117.1 | 69.7 | 127.3 | 108.6 | 14.7 | Dipper | 126.2 | 9.44 | 35.7 | 14.5 | 17.5 | 1 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 84.7 | 22.3 | 1 | Hyperkalemia | 3 | 33 | 3,906 | 18.1 | 4.6 | 6.7 | Never | 4.2 | 12.2 | 223.7 | 70.8 | 64.5 | 264.8 | 159.2 | 0.72 | 1.09 | 72.3 | 22.9 | G2 | 11.7 | 4.41 | 141.3 | 130.7 | 6.5 | 6.3 | 15.3 | 1.56 | 75 | 50 | 0 | 0 | 0 | 62.2 | 55 | 9 | 1.5 | 1 | 0 | 5.59 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 5 | 2016-04-01 | 1.25 | 79.2 | Female | NonHispanic_White | Stage1_HTN | 137.2 | 83.6 | 53.6 | 101.5 | 132.4 | 81.2 | 125.2 | 78.5 | 127.3 | 107.1 | 15.8 | Dipper | 123.1 | 9.89 | 38.4 | 9 | 4.8 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 81.9 | 25.1 | 1 | None | 3 | 33.1 | 3,849 | 18.3 | 3.3 | 7 | Never | 3.9 | 15.7 | 216.3 | 84.3 | 65 | 241.4 | 151.3 | 0.82 | 0.91 | 64.4 | 34.4 | G2 | 9.8 | 4.35 | 141.5 | 126.8 | 6.5 | 5.5 | 9.6 | 2.62 | 75 | 50 | 1 | 0 | 0 | 62.3 | 58.7 | 8.9 | 1.5 | 1 | 0 | 4.74 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 6 | 2016-07-01 | 1.5 | 79.5 | Female | NonHispanic_White | Stage1_HTN | 132.8 | 82 | 50.8 | 98.9 | 114 | 72.6 | 108.5 | 67.9 | 117.8 | 103.3 | 12.3 | Dipper | 117.9 | 10 | 35.3 | 10.7 | 18.8 | 1 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 89.4 | 29.8 | 1 | None | 3 | 33 | 3,908 | 18.3 | 3.8 | 7.1 | Never | 3.9 | 9 | 222.5 | 78.4 | 64.9 | 303.7 | 157.6 | 0.69 | 0.95 | 64.8 | 29.2 | G2 | 6.9 | 4.26 | 142 | 133.6 | 6.6 | 5.4 | 7.6 | 1.46 | 75 | 50 | 0 | 0 | 0 | 60 | 55.1 | 9.2 | 1.5 | 1 | 0 | 5.22 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 7 | 2016-10-01 | 1.75 | 79.8 | Female | NonHispanic_White | Stage1_HTN | 125.9 | 77.6 | 48.3 | 93.7 | 114.9 | 72.1 | 110.7 | 72.4 | 114.6 | 103.7 | 9.6 | Non-dipper | 115.4 | 10.05 | 38.5 | 6.6 | 11 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 83.4 | 28.9 | 0 | None | 3 | 33.4 | 3,940 | 16.4 | 1.5 | 6.9 | Never | 3.6 | 13.8 | 220.5 | 69.2 | 64.3 | 220.2 | 156.3 | 0.69 | 1.11 | 73.9 | 17.2 | G2 | 12.9 | 4.58 | 139.5 | 134 | 6.7 | 5.8 | 9.3 | 2.56 | 75 | 50 | 0 | 0 | 0 | 62.9 | 55.6 | 9.7 | 1.5 | 1 | 0 | 5.26 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 8 | 2017-01-01 | 2 | 80 | Female | NonHispanic_White | Stage1_HTN | 135.3 | 85.2 | 50.1 | 101.9 | 134.8 | 85 | 134.8 | 83.7 | 141.9 | 132.7 | 6.5 | Non-dipper | 125.3 | 10.23 | 36.5 | 12.1 | 0.6 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 86 | 29.6 | 1 | None | 3 | 33.6 | 3,765 | 17.4 | 4.3 | 7.2 | Never | 3.8 | 13.7 | 227.4 | 85.2 | 60.4 | 250.2 | 167 | 0.67 | 1 | 73.9 | 29 | G2 | 11.9 | 4.71 | 143.3 | 131.4 | 6.5 | 6.1 | 10.4 | 1.1 | 75 | 50 | 0 | 0 | 0 | 60 | 56.9 | 9.6 | 1.5 | 1 | 0 | 5.46 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 9 | 2017-04-01 | 2.25 | 80.2 | Female | NonHispanic_White | Stage1_HTN | 118.4 | 81.6 | 36.8 | 93.9 | 108.2 | 76.6 | 108.3 | 75.1 | 106.6 | 101.1 | 5.2 | Non-dipper | 112.5 | 9.58 | 35.7 | 18.6 | 10.1 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 88.5 | 27.6 | 0 | Hyperkalemia | 3 | 33.3 | 3,798 | 22 | 5.1 | 7.2 | Never | 4 | 14.8 | 218.8 | 62.9 | 62.4 | 252 | 156.3 | 0.99 | 1.04 | 65.1 | 31.2 | G2 | 11.4 | 4.2 | 142.9 | 126.8 | 6.6 | 5.6 | 6.7 | 1.48 | 75 | 50 | 1 | 0 | 0 | 60 | 59.1 | 8.7 | 1.5 | 1 | 0 | 5.85 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 10 | 2017-07-01 | 2.5 | 80.5 | Female | NonHispanic_White | Stage1_HTN | 116.3 | 81.2 | 35 | 92.9 | 105 | 75.6 | 103 | 71.2 | 108.5 | 90.6 | 16.5 | Dipper | 101.7 | 10.31 | 34.6 | 6.7 | 11.3 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 84.3 | 23.8 | 0 | Dry_Cough | 3 | 33.3 | 3,806 | 22.8 | 4.9 | 6.8 | Never | 2.8 | 12 | 221.4 | 75.3 | 65.3 | 215.2 | 156.1 | 0.91 | 1.13 | 68.7 | 38.5 | G2 | 10.1 | 4.42 | 141.1 | 137.5 | 6.6 | 5.7 | 12.8 | 1.58 | 75 | 50 | 1 | 0 | 0 | 64.6 | 60.2 | 8.9 | 1.499 | 1 | 0 | 5.56 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 11 | 2017-10-01 | 2.75 | 80.8 | Female | NonHispanic_White | Stage1_HTN | 125.5 | 82.2 | 43.2 | 96.6 | 124.4 | 81.7 | 122.1 | 76.4 | 128 | 112 | 12.5 | Dipper | 117.2 | 9.78 | 38 | 7 | 1.1 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 83.7 | 25.6 | 0 | None | 3 | 33.4 | 3,948 | 17.7 | 3.8 | 7 | Never | 3.9 | 8.7 | 226.9 | 81.9 | 64.1 | 243.1 | 162.8 | 0.64 | 0.98 | 65.6 | 31.4 | G2 | 13 | 4.79 | 144.6 | 127.7 | 6.7 | 6 | 9.1 | 2.93 | 75 | 50 | 1 | 0 | 0 | 60.9 | 58.8 | 11.1 | 1.5 | 1 | 0 | 5.86 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000149 | 12 | 2018-01-01 | 3 | 81 | Female | NonHispanic_White | Stage1_HTN | 118.4 | 78.5 | 40 | 91.8 | 110.9 | 74.7 | 104.9 | 74 | 113.2 | 98 | 13.4 | Dipper | 111.8 | 9.27 | 34.4 | 17.1 | 7.6 | 0 | 0 | CCB | Diltiazem | 10mg | ACE_inhibitor | Lisinopril | MRA | Eplerenone | None | None | 3 | 80.3 | 26.5 | 0 | None | 3 | 33.3 | 3,890 | 22.8 | 3.1 | 6.7 | Never | 4.1 | 12.3 | 224.7 | 70.4 | 68 | 215.4 | 156.7 | 0.71 | 0.93 | 67.7 | 22.9 | G2 | 8.7 | 4.65 | 141.3 | 140.2 | 6.6 | 5.8 | 6.9 | 1.94 | 75 | 50 | 0 | 0 | 0 | 60.1 | 61.4 | 9.1 | 1.5 | 1 | 0 | 5.71 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
HC-CAR-000150 | 1 | 2015-04-01 | 0.25 | 68.8 | Female | NonHispanic_White | Crisis | 173.3 | 120 | 53.3 | 137.8 | 173.5 | 120.1 | 175.8 | 120 | 184.5 | 176.5 | 4.4 | Non-dipper | 164.4 | 13.37 | 33.6 | 10.5 | -0.2 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 94.3 | 15 | 0 | Bradycardia | 2 | 28 | 3,908 | 38.2 | 5.5 | 7.9 | Former | 11 | 3.2 | 215.9 | 149.5 | 65.5 | 269.5 | 150.4 | 1.91 | 1.27 | 56.3 | 272.3 | G3a | 6.1 | 3.78 | 139.8 | 113.4 | 7.2 | 4.9 | 13.5 | 3.53 | 75 | 50 | 1 | 0 | 0 | 113.6 | 62.4 | 5.2 | 1.498 | 1 | 0 | 8.08 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 2 | 2015-07-01 | 0.5 | 69.1 | Female | NonHispanic_White | Crisis | 180 | 119.8 | 60.3 | 139.9 | 173.3 | 116.4 | 173.5 | 115.2 | 183.1 | 154.5 | 15.6 | Dipper | 168 | 13.53 | 32.7 | 21.3 | 6.7 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 92.6 | 11.5 | 0 | None | 2 | 28 | 4,076 | 35.1 | 8.1 | 8.2 | Former | 10.8 | 3.7 | 220.3 | 161.9 | 66.6 | 211.9 | 153.8 | 1.16 | 1.37 | 58.5 | 205.7 | G3a | 6.5 | 3.86 | 140.6 | 132.8 | 7.4 | 4.7 | 30.1 | 2.83 | 75 | 50 | 1 | 0 | 0 | 114.1 | 65.5 | 5 | 1.496 | 1 | 0 | 8.18 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 3 | 2015-10-01 | 0.75 | 69.3 | Female | NonHispanic_White | Crisis | 174.3 | 117.2 | 57.1 | 136.2 | 169.7 | 114.9 | 166.4 | 111.5 | 171.6 | 164.9 | 3.9 | Non-dipper | 161.1 | 12.88 | 35.5 | 8.5 | 4.6 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 89 | 17.2 | 0 | None | 2 | 28 | 4,036 | 38.4 | 5.3 | 8.5 | Former | 10.5 | 3.1 | 219.2 | 156.5 | 65.2 | 220 | 154 | 1.74 | 1.32 | 50.5 | 202.6 | G3a | 5.3 | 3.89 | 140 | 134.9 | 7.2 | 5.2 | 34.5 | 2.81 | 75 | 50 | 1 | 0 | 0 | 116.3 | 63 | 5.5 | 1.5 | 1 | 0 | 8.11 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 4 | 2016-01-01 | 1 | 69.6 | Female | NonHispanic_White | Crisis | 168.7 | 113.9 | 54.8 | 132.2 | 165.7 | 112.4 | 168.1 | 113.1 | 179.1 | 171.3 | 4.3 | Non-dipper | 162.3 | 12.87 | 35.2 | 11.9 | 3.1 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 80.6 | 15.1 | 0 | None | 2 | 28.2 | 3,887 | 34 | 7.9 | 8.1 | Former | 11.7 | 2.1 | 214.6 | 156.2 | 64.2 | 215.8 | 150.4 | 1.28 | 1.34 | 49.3 | 222.2 | G3a | 8.2 | 3.85 | 139.9 | 112.6 | 7.5 | 5 | 33.6 | 5.35 | 75 | 50 | 1 | 0 | 0 | 112.3 | 63.2 | 5 | 1.5 | 1 | 0 | 7.37 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 5 | 2016-04-01 | 1.25 | 69.8 | Female | NonHispanic_White | Crisis | 160.8 | 122.1 | 38.7 | 135 | 144.5 | 113.9 | 146.5 | 110.1 | 158.8 | 136.4 | 14.2 | Dipper | 154.1 | 13.4 | 33.3 | 7.9 | 16.3 | 1 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 86.4 | 21 | 0 | None | 2 | 28.2 | 4,022 | 35.6 | 7.5 | 8.4 | Former | 10.4 | 4.3 | 226.3 | 150.2 | 64.6 | 284.6 | 161.6 | 2.41 | 1.33 | 52.5 | 266.9 | G3a | 8.9 | 4.1 | 141.9 | 131.9 | 7.1 | 4.4 | 39.7 | 2.1 | 75 | 50 | 1 | 0 | 0 | 114 | 64.8 | 6.5 | 1.5 | 1 | 0 | 8 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 6 | 2016-07-01 | 1.5 | 70.1 | Female | NonHispanic_White | Crisis | 172.8 | 120.9 | 51.9 | 138.2 | 170.5 | 119.7 | 171.2 | 119.2 | 179.5 | 162.1 | 9.7 | Non-dipper | 160.8 | 13.85 | 31.5 | 13.4 | 2.4 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 87.2 | 23.1 | 0 | None | 2 | 28.2 | 3,882 | 36.1 | 6.4 | 8.2 | Former | 10 | 2 | 223.7 | 157.9 | 66.4 | 242.9 | 157.2 | 2.31 | 1.34 | 44.8 | 366.5 | G3b | 10 | 3.66 | 140 | 137.8 | 7.3 | 5.1 | 22.2 | 1.64 | 75 | 50 | 0 | 1 | 0 | 114.4 | 63.5 | 5.4 | 1.492 | 1 | 0 | 7.65 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 7 | 2016-10-01 | 1.75 | 70.3 | Female | NonHispanic_White | Crisis | 172.2 | 119.8 | 52.5 | 137.3 | 168.2 | 117.8 | 167.9 | 115.3 | 176.3 | 150.8 | 14.5 | Dipper | 160 | 13.58 | 31.9 | 17.2 | 4 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 85.5 | 11.7 | 0 | None | 2 | 28.3 | 3,920 | 37.5 | 9.7 | 8 | Former | 10.2 | 1 | 229 | 160.3 | 68 | 250.6 | 161 | 1.96 | 1.33 | 54.2 | 285.6 | G3a | 7 | 3.76 | 142 | 136.1 | 7.6 | 5.1 | 31.6 | 1.62 | 75 | 50 | 1 | 0 | 0 | 118.3 | 67 | 5.9 | 1.5 | 1 | 0 | 8.08 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 8 | 2017-01-01 | 2 | 70.6 | Female | NonHispanic_White | Crisis | 184.1 | 115 | 69.1 | 138 | 179.2 | 112.5 | 179.5 | 110.2 | 189.1 | 164.4 | 13.1 | Dipper | 171.8 | 13.16 | 33 | 13.5 | 4.9 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 96.2 | 18.5 | 0 | None | 2 | 28.1 | 4,031 | 37.9 | 5.7 | 8.2 | Former | 10.9 | 5.9 | 224.4 | 155.8 | 65.1 | 239.8 | 159.3 | 1.66 | 1.32 | 50.5 | 230.9 | G3a | 9.2 | 3.96 | 139.9 | 124 | 7.3 | 4.7 | 21.8 | 1.64 | 75 | 50 | 1 | 0 | 0 | 114.2 | 63.4 | 5.9 | 1.5 | 1 | 0 | 7.79 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 9 | 2017-04-01 | 2.25 | 70.8 | Female | NonHispanic_White | Crisis | 176.6 | 123.6 | 52.9 | 141.3 | 163.9 | 117.3 | 154.3 | 117.6 | 162 | 142.3 | 12.2 | Dipper | 167 | 12.82 | 33 | 10.7 | 12.7 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 84.3 | 5.6 | 0 | None | 2 | 28.1 | 3,885 | 37.5 | 6.4 | 8.1 | Former | 11 | 2.2 | 218.1 | 164.7 | 60.4 | 262.9 | 157.7 | 1.95 | 1.35 | 49.9 | 224.2 | G3a | 11.7 | 4.02 | 139 | 135.1 | 7.3 | 4.6 | 14.7 | 1.73 | 75 | 50 | 1 | 0 | 0 | 113.5 | 61.5 | 5 | 1.5 | 1 | 0 | 7.46 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 10 | 2017-07-01 | 2.5 | 71.1 | Female | NonHispanic_White | Crisis | 168 | 122.7 | 45.3 | 137.8 | 165.9 | 121.7 | 162.8 | 119.1 | 168.2 | 151 | 10.3 | Dipper | 159.5 | 12.97 | 33.5 | 18.4 | 2.1 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 88.8 | 21.2 | 0 | None | 2 | 28.2 | 3,878 | 40.5 | 7.1 | 8.1 | Former | 11.1 | 4.8 | 226.9 | 152.8 | 64.1 | 244.7 | 162.7 | 1.8 | 1.41 | 47.7 | 264.6 | G3a | 7.3 | 3.98 | 138.6 | 118.8 | 7.1 | 4.5 | 30.3 | 6.25 | 75 | 50 | 1 | 0 | 0 | 116 | 67.3 | 5.5 | 1.5 | 1 | 0 | 8.04 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 11 | 2017-10-01 | 2.75 | 71.3 | Female | NonHispanic_White | Crisis | 174.1 | 126.8 | 47.3 | 142.6 | 159.9 | 119.7 | 158 | 117.4 | 170.4 | 153.5 | 9.9 | Non-dipper | 160.6 | 13.6 | 33.3 | 22.1 | 14.2 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 93.8 | 30.1 | 0 | None | 2 | 28.6 | 3,840 | 37 | 7 | 8.1 | Former | 10.5 | 2.3 | 219.2 | 152.5 | 65.3 | 244.7 | 154 | 1.9 | 1.31 | 53.3 | 176.9 | G3a | 5.6 | 4.05 | 139.6 | 131.5 | 7 | 5.4 | 16.3 | 4.04 | 75 | 50 | 1 | 0 | 0 | 115.1 | 66.2 | 5.9 | 1.5 | 1 | 0 | 7.88 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
HC-CAR-000150 | 12 | 2018-01-01 | 3 | 71.6 | Female | NonHispanic_White | Crisis | 180.4 | 107.5 | 72.9 | 131.8 | 171.3 | 102.9 | 177.3 | 98 | 183.5 | 161.4 | 12.1 | Dipper | 170.5 | 14.46 | 37.9 | 7.6 | 9.1 | 0 | 0 | Beta_blocker | Bisoprolol | 10mg | ARB | Telmisartan | None | None | None | None | 2 | 80.5 | 20 | 0 | None | 2 | 28.5 | 4,109 | 42.2 | 7.4 | 8.3 | Former | 9.8 | 1.9 | 219.4 | 149.7 | 60.9 | 224.9 | 158.5 | 1.6 | 1.37 | 56.4 | 226.5 | G3a | 9.1 | 3.79 | 139.1 | 120.1 | 7.2 | 4.7 | 29.3 | 2.87 | 75 | 50 | 1 | 0 | 0 | 115.9 | 65.5 | 5.3 | 1.5 | 1 | 0 | 8.09 | 0 | 0 | None | 0 | 0 | None | 0 | 0 | 0 | 0 | 0 | None | 1 | 1 | 0 | 1 | 0 | 1 | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.